Chemical and Pharmaceutical Bulletin p. 2287 - 2293 (1996)
Update date:2022-07-31
Topics:
Matsuoka, Hiroharu
Maruyama, Noriaki
Suzuki, Hiroshi
Kuroki, Toshio
Tsuji, Keiichiro
Kato, Nobuaki
Ohi, Nobuhiro
Mihara, Masahiko
Takeda, Yasuhisa
Yano, Keiichi
Novel methotrexate (MTX) derivatives with either a mono- or dialkyl- substituted benzene ring were synthesized and initially tested for in vitro anti-proliferative activities using human peripheral blood mononuclear cells (hPBMC) derived from healthy volunteers and synovial cells (hSC) derived from patients with rheumatoid arthritis (RA). Compounds with potent activities were further evaluated in an in vivo adjuvant arthritis model. In comparison with MTX, a glutamate derivative 3a was more potent as a suppressor of the in vitro cell proliferation and the in vivo experimental arthritis, and a homoglutamate derivative, 3e, exhibited fairly good activities in vitro and considerable activity in vivo in a dose-dependent manner. As expected, 3e did not act as a substrate of folylpolyglutamate synthetase (FPGS), and thus did not undergo polyglutamation, which is thought to be responsible for side-effects that occur during MTX therapy.
View MoreSuzhou Ryan Pharmachem Technology Co.,Ltd
Contact:+86-0512-68780025
Address:B-301,No.2 Taishan Road,Suzhou New District,Jiangsu,P.R. China
Zibo Kunran Enterprises Co. LTD
website:http://www.kunranchem.com
Contact:0086 533 5200669
Address:No. 96 Jinjing Avenue, Zibo, Shandong, China
website:https://www.yurisolar.com/en
Contact:86--18092602675
Address:No. 560, East Hangtian Road, Xi'an, China
Melone Pharmaceutical Co., ltd
Contact:+86-411 82593920, 82593631
Address:No 232, JInma Roda, Development Zone, Dalian, China
Shaanxi HuaTai Bio-fine chemical company Ltd
Contact:86-029-87862197
Address:No. 5, 3rd Floor, 29 Yanta North Road, Beilin Dist.
Doi:10.1021/jo01266a004
(1968)Doi:10.1016/S0040-4039(00)73957-8
(1993)Doi:10.1248/cpb.52.1367
(2004)Doi:10.1107/S0108270193007759
(1994)Doi:10.1016/0022-328X(93)83277-3
(1993)Doi:10.1016/j.bioorg.2019.103217
(2019)
